AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 15 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,842 | +80744.9% | 15,295 | 0.0% | 0.00% | – |
| Q2 2023 | $147 | -12.5% | 15,295 | 0.0% | 0.00% | – |
| Q1 2023 | $168 | +154.5% | 15,295 | +0.3% | 0.00% | – |
| Q4 2022 | $66 | -99.9% | 15,247 | 0.0% | 0.00% | – |
| Q3 2022 | $115,000 | -24.8% | 15,247 | -0.6% | 0.00% | – |
| Q2 2022 | $153,000 | -19.5% | 15,335 | 0.0% | 0.00% | – |
| Q1 2022 | $190,000 | -45.9% | 15,335 | 0.0% | 0.00% | – |
| Q4 2021 | $351,000 | -50.4% | 15,335 | -64.4% | 0.00% | -100.0% |
| Q3 2021 | $707,000 | +258.9% | 43,135 | +183.3% | 0.00% | – |
| Q2 2021 | $197,000 | +7.7% | 15,225 | +8.9% | 0.00% | – |
| Q1 2021 | $183,000 | +66.4% | 13,979 | +74.2% | 0.00% | – |
| Q4 2020 | $110,000 | -22.5% | 8,024 | -16.8% | 0.00% | – |
| Q3 2020 | $142,000 | -42.5% | 9,641 | -36.6% | 0.00% | -100.0% |
| Q2 2020 | $247,000 | +79.0% | 15,210 | +59.9% | 0.00% | – |
| Q1 2020 | $138,000 | -79.0% | 9,512 | -70.7% | 0.00% | -100.0% |
| Q4 2019 | $658,000 | +826.8% | 32,509 | +145.8% | 0.00% | – |
| Q3 2019 | $71,000 | -56.2% | 13,224 | -46.5% | 0.00% | – |
| Q2 2019 | $162,000 | +157.1% | 24,710 | +152.7% | 0.00% | – |
| Q1 2019 | $63,000 | +57.5% | 9,780 | +64.7% | 0.00% | – |
| Q4 2018 | $40,000 | +14.3% | 5,938 | +12.0% | 0.00% | – |
| Q3 2018 | $35,000 | +6.1% | 5,300 | -7.5% | 0.00% | – |
| Q2 2018 | $33,000 | – | 5,730 | +143150.0% | 0.00% | – |
| Q4 2016 | $0 | – | 4 | -94.1% | 0.00% | – |
| Q3 2016 | $0 | – | 68 | +423.1% | 0.00% | – |
| Q2 2016 | $0 | – | 13 | -63.9% | 0.00% | – |
| Q1 2016 | $0 | – | 36 | -29.4% | 0.00% | – |
| Q4 2015 | $0 | – | 51 | -1.9% | 0.00% | – |
| Q3 2015 | $0 | – | 52 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 230,000 | $993,600 | 1.92% |
| AlphaCentric Advisors LLC | 352,500 | $1,522,800 | 1.50% |
| NEA Management Company, LLC | 3,969,834 | $17,149,683 | 0.96% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 573,530 | $2,477,650 | 0.76% |
| ARMISTICE CAPITAL, LLC | 5,000,000 | $21,600,000 | 0.38% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 93,658 | $404,603 | 0.27% |
| Artal Group S.A. | 1,000,000 | $4,320 | 0.24% |
| Virtus ETF Advisers LLC | 64,786 | $279,876 | 0.15% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $864,000 | 0.13% |
| HighMark Wealth Management LLC | 37,499 | $161,996 | 0.12% |